AH043 - Pharmacy Benefits 101: DMP & MTM, Explained, with Nash Albadarin, PharmD

This episode of the Astonishing Healthcare podcast covers the ins and outs of two programs in the government sector - i.e., Medicare and Medicaid - and how modern technology - JUDI® - allows for more agility and flexibility in delivering care to Part D plan members and meeting CMS requirements. Capital Rx's Nash Albadarin, PharmD, explains changes to the Medication Therapy Management (MTM) criteria for 2025, which will increase membership, and provides an update on how MTM impacts Medicare star ratings. He also describes the purpose and structure of the Drug Management Program (DMP), which aims to help limit the risks associated with misuse and overuse of prescription drugs, namely opioids and other frequently abused, high-risk drugs.Additionally, Nash highlights the utility of these programs and their potential beyond the government sector, as MTM and mitigating the risks associated with opioids, for example, can help other plan sponsors better manage their populations.Related ContentPharmacy Benefits 101: What's the Drug Management Program (DMP)?AH005 - Star Ratings, MTM, & CMS Translation Requirements with Jay Tran, PharmDPharmacy Benefits 101: Medicare Star RatingsAH035 - Pharmacy Benefits 101: Clinical Programs, with Bonnie Hui-Callahan, PharmDFor more information about Capital Rx and this episode, please visit Capital Rx Insights.